CANF ADR trading at $6.46 Started a position in CANF. News due before the end of the year on 2 studies. http://finance.yahoo.com/news/fite-ceo-issues-letter-shareholders-120000151.html More info from a WSJ article here: http://online.wsj.com/article/PR-CO-20131120-904735.html Priced below October offering of $6.60 Lots of action here, though not the traditional FDA pathway.